CompletedNCT01157715
A Randomized, Double-masked, Multicenter, Controlled Study of Intravitreal KH902 in Patients With Neovascular AMD
PHASE2 · 122 planned enrolment
- Countries listed
- 1
- Registry update
- November 6, 2014
immortal.lifeTrial registrations containing the exact intervention label intravitreal injection of KH902.
No aliases or equivalent products have been inferred.
This is a registry availability fact, not a safety result, comparison, or conclusion.
Understand the safety boundary →PHASE2 · 122 planned enrolment
PHASE1 · PHASE2 · 36 planned enrolment